Mark Berger

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for treatment of patients with myelodysplastic syndromes
- Patent number 12,083,192
- Issue date Sep 10, 2024
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CD45-based conditioning methods and uses thereof in conjunctio...
- Patent number 11,912,780
- Issue date Feb 27, 2024
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
- Publication number 20240408250
- Publication date Dec 12, 2024
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJ...
- Publication number 20240299600
- Publication date Sep 12, 2024
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTIO...
- Publication number 20240158528
- Publication date May 16, 2024
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF CANCERS
- Publication number 20230092668
- Publication date Mar 23, 2023
- ACTINIUM PHARMACEUTICALS, INC.
- Mary M. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJCTI...
- Publication number 20210198359
- Publication date Jul 1, 2021
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A H...
- Publication number 20210179710
- Publication date Jun 17, 2021
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOG...
- Publication number 20200308280
- Publication date Oct 1, 2020
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
- Publication number 20200276339
- Publication date Sep 3, 2020
- Actinium Pharmaceuticals, Inc.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTIO...
- Publication number 20200255520
- Publication date Aug 13, 2020
- ACTINIUM PHARMACEUTICALS, INC.
- Mark Berger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Berger

Person

Patents Grantslast 30 patents

Methods for treatment of patients with myelodysplastic syndromes

Anti-CD45-based conditioning methods and uses thereof in conjunctio...

Patents Applicationslast 30 patents

METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJ...

ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTIO...

RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF CANCERS

ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJCTI...

COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A H...

METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOG...

METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTIO...